GSK has applied to the US Food and Drug Administration (FDA) to extend use of its respiratory syncytial virus (RSV) vaccine Arexvy to adults under the age of 50 who are at increased risk of the ...

Health experts on Monday encouraged Filipinos, especially young ones and senior citizens, to get their annual anti-flu shot ...